Arch Biopartners Inc.

5 enregistrements totalisant 9,805,265.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Innovation, Sciences et Développement économique Canada $5,407,235 1 enregistrement
Conseil national de recherches Canada $4,398,030 4 enregistrements

Enregistrements

Arch Biopartners Inc. $5,407,235.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
SIF Stream 1- R&D
EF 2020-2021
Canada

This project is to advance a lead therapeutic drug candidate through Phase II clinical trials to treat severe cases of COVID-19, specifically in the lungs, kidney and liver.

Arch Biopartners Inc. $4,000,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada

The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who have moderate to severe COVID-19 and other diseases. LSALT peptide is a novel drug candid...

Arch Biopartners Inc. $200,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2018-2019
Canada

LSALT is a peptide drug and a selective non-enzymatic dipeptidase-1 antagonist and prevents leukocyte adhesion to endothelial cells creating numerous indications for targeting inflammation in the cont...

ARCH BIOPARTNERS INC. $107,000.00
National Research Council Canada | Conseil national de recherches Canada
EF 2011-2012
Canada
ARCH BIOPARTNERS INC. $91,030.00
National Research Council Canada | Conseil national de recherches Canada
EF 2013-2014
Canada